MovDisordV3, Main, Exploration, bibRecord, 002788

Levodopa might affect metaiodobenzylguanidine myocardial accumulation

Identifieur interne : 002788 ( Main/Exploration ); précédent : 002787; suivant : 002789

Levodopa might affect metaiodobenzylguanidine myocardial accumulation

Auteurs : Fuyuki Tateno [Japon] ; Ryuji Sakakibara [Japon] ; Atsuhito Saiki [Japon] ; You Miyashita [Japon] ; Koji Shirai [Japon]

Source :

Movement Disorders [ 0885-3185 ] ; 2008-10-30.

RBID : ISTEX:DD7B3A36434FEF4A86733D7E28D9882643AD37F7

English descriptors

KwdEn :
- 3-Iodobenzylguanidine (metabolism), Adult, Dopamine Agents (administration & dosage), Humans, Levodopa (administration & dosage), Male, Myocardium (metabolism), Tremor (drug therapy).
MESH :
- chemical , administration & dosage : Dopamine Agents, Levodopa.
- chemical , metabolism : 3-Iodobenzylguanidine.
- drug therapy : Tremor.
- metabolism : Myocardium.
- Adult, Humans, Male.

Url:

https://api.istex.fr/document/DD7B3A36434FEF4A86733D7E28D9882643AD37F7/fulltext/pdf

DOI: 10.1002/mds.22015

Affiliations:

Japon

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Levodopa might affect metaiodobenzylguanidine myocardial accumulation</title>
<author><name sortKey="Tateno, Fuyuki" sort="Tateno, Fuyuki" uniqKey="Tateno F" first="Fuyuki" last="Tateno">Fuyuki Tateno</name>
</author>
<author><name sortKey="Sakakibara, Ryuji" sort="Sakakibara, Ryuji" uniqKey="Sakakibara R" first="Ryuji" last="Sakakibara">Ryuji Sakakibara</name>
</author>
<author><name sortKey="Saiki, Atsuhito" sort="Saiki, Atsuhito" uniqKey="Saiki A" first="Atsuhito" last="Saiki">Atsuhito Saiki</name>
</author>
<author><name sortKey="Miyashita, You" sort="Miyashita, You" uniqKey="Miyashita Y" first="You" last="Miyashita">You Miyashita</name>
</author>
<author><name sortKey="Shirai, Koji" sort="Shirai, Koji" uniqKey="Shirai K" first="Koji" last="Shirai">Koji Shirai</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:DD7B3A36434FEF4A86733D7E28D9882643AD37F7</idno>
<date when="2008" year="2008">2008</date>
<idno type="doi">10.1002/mds.22015</idno>
<idno type="url">https://api.istex.fr/document/DD7B3A36434FEF4A86733D7E28D9882643AD37F7/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002350</idno>
<idno type="wicri:Area/Istex/Curation">002350</idno>
<idno type="wicri:Area/Istex/Checkpoint">001344</idno>
<idno type="wicri:doubleKey">0885-3185:2008:Tateno F:levodopa:might:affect</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:18785216</idno>
<idno type="wicri:Area/PubMed/Corpus">002046</idno>
<idno type="wicri:Area/PubMed/Curation">002046</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002239</idno>
<idno type="wicri:Area/Ncbi/Merge">002317</idno>
<idno type="wicri:Area/Ncbi/Curation">002317</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002317</idno>
<idno type="wicri:Area/Main/Merge">003366</idno>
<idno type="wicri:Area/Main/Curation">002788</idno>
<idno type="wicri:Area/Main/Exploration">002788</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Levodopa might affect metaiodobenzylguanidine myocardial accumulation</title>
<author><name sortKey="Tateno, Fuyuki" sort="Tateno, Fuyuki" uniqKey="Tateno F" first="Fuyuki" last="Tateno">Fuyuki Tateno</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Internal Medicine, Neurology Division, Sakura Medical Center, Toho University, Sakura</wicri:regionArea>
<wicri:noRegion>Sakura</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Internal Medicine, Endocrinology and Metabolism Division, Sakura Medical Center, Toho University, Sakura</wicri:regionArea>
<wicri:noRegion>Sakura</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sakakibara, Ryuji" sort="Sakakibara, Ryuji" uniqKey="Sakakibara R" first="Ryuji" last="Sakakibara">Ryuji Sakakibara</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Internal Medicine, Neurology Division, Sakura Medical Center, Toho University, Sakura</wicri:regionArea>
<wicri:noRegion>Sakura</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Saiki, Atsuhito" sort="Saiki, Atsuhito" uniqKey="Saiki A" first="Atsuhito" last="Saiki">Atsuhito Saiki</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Internal Medicine, Endocrinology and Metabolism Division, Sakura Medical Center, Toho University, Sakura</wicri:regionArea>
<wicri:noRegion>Sakura</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Miyashita, You" sort="Miyashita, You" uniqKey="Miyashita Y" first="You" last="Miyashita">You Miyashita</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Internal Medicine, Endocrinology and Metabolism Division, Sakura Medical Center, Toho University, Sakura</wicri:regionArea>
<wicri:noRegion>Sakura</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Shirai, Koji" sort="Shirai, Koji" uniqKey="Shirai K" first="Koji" last="Shirai">Koji Shirai</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Internal Medicine, Endocrinology and Metabolism Division, Sakura Medical Center, Toho University, Sakura</wicri:regionArea>
<wicri:noRegion>Sakura</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2008-10-30">2008-10-30</date>
<biblScope unit="vol">23</biblScope>
<biblScope unit="issue">14</biblScope>
<biblScope unit="page" from="2097">2097</biblScope>
<biblScope unit="page" to="2098">2098</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">DD7B3A36434FEF4A86733D7E28D9882643AD37F7</idno>
<idno type="DOI">10.1002/mds.22015</idno>
<idno type="ArticleID">MDS22015</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>3-Iodobenzylguanidine (metabolism)</term>
<term>Adult</term>
<term>Dopamine Agents (administration & dosage)</term>
<term>Humans</term>
<term>Levodopa (administration & dosage)</term>
<term>Male</term>
<term>Myocardium (metabolism)</term>
<term>Tremor (drug therapy)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Dopamine Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>3-Iodobenzylguanidine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Tremor</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Myocardium</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Humans</term>
<term>Male</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>Japon</li>
</country>
</list>
<tree><country name="Japon"><noRegion><name sortKey="Tateno, Fuyuki" sort="Tateno, Fuyuki" uniqKey="Tateno F" first="Fuyuki" last="Tateno">Fuyuki Tateno</name>
</noRegion>
<name sortKey="Miyashita, You" sort="Miyashita, You" uniqKey="Miyashita Y" first="You" last="Miyashita">You Miyashita</name>
<name sortKey="Saiki, Atsuhito" sort="Saiki, Atsuhito" uniqKey="Saiki A" first="Atsuhito" last="Saiki">Atsuhito Saiki</name>
<name sortKey="Sakakibara, Ryuji" sort="Sakakibara, Ryuji" uniqKey="Sakakibara R" first="Ryuji" last="Sakakibara">Ryuji Sakakibara</name>
<name sortKey="Shirai, Koji" sort="Shirai, Koji" uniqKey="Shirai K" first="Koji" last="Shirai">Koji Shirai</name>
<name sortKey="Tateno, Fuyuki" sort="Tateno, Fuyuki" uniqKey="Tateno F" first="Fuyuki" last="Tateno">Fuyuki Tateno</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002788 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002788 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:DD7B3A36434FEF4A86733D7E28D9882643AD37F7
   |texte=   Levodopa might affect metaiodobenzylguanidine myocardial accumulation
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

Movement Disorders (revue)

Levodopa might affect metaiodobenzylguanidine myocardial accumulation

Levodopa might affect metaiodobenzylguanidine myocardial accumulation

Source :

English descriptors

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.